Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes. - sprookjes - yvandenbroek - TriplyDB

Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes.

Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes.

http://www.wikidata.org/entity/Q34750590

about

Bone Marrow Immunity and Myelodysplasia Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of TPO receptor agonists in aplastic anemia and myelodysplastic syndromes Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes Eltrombopag in aplastic anemia IPSS-independent prognostic value of plasma CXCL10, IL-7 and IL-6 levels in myelodysplastic syndromes Decreased plasma cytokines are associated with low platelet counts in aplastic anemia and immune thrombocytopenic purpura.The innateness of platelets.Increased plasma thrombopoietin levels in patients with myelodysplastic syndrome: a reliable marker for a benign subset of bone marrow failure.Bone marrow hypocellularity does not affect tolerance or efficacy of azacitidine in patients with higher-risk myelodysplastic syndromes.Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug.Hematopoietic RIPK1 deficiency results in bone marrow failure caused by apoptosis and RIPK3-mediated necroptosis.Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia.Pathogenesis of myelodysplastic syndromes: an overview of molecular and non-molecular aspects of the disease.Circulating thrombopoietin levels in normal healthy blood donors and in aplastic anemia patients in relation to disease severity Increased expression of interferon signaling genes in the bone marrow microenvironment of myelodysplastic syndromes.Immune-mediated bone marrow failure in C57BL/6 mice Eltrombopag and improved hematopoiesis in refractory aplastic anemia.The Systemic Profile of Soluble Immune Mediators in Patients with Myelodysplastic Syndromes.Dynamic alterations of bone marrow cytokine landscape of myelodysplastic syndromes patients treated with 5-azacytidine.A plasma microRNA signature as a biomarker for acquired aplastic anemia.Diagnosis of acquired aplastic anemia.The possible diagnostic and prognostic use of systemic chemokine profiles in clinical medicine—the experience in acute myeloid leukemia from disease development and diagnosis via conventional chemotherapy to allogeneic stem cell transplantation.Border between aplastic anemia and myelodysplastic syndrome.GATA2 regulates differentiation of bone marrow-derived mesenchymal stem cells.Involvement of interleukin-21 in the pathophysiology of aplastic anemia.New frontiers for platelet CD154.Persistent elevation of plasma thrombopoietin levels after treatment in severe aplastic anemia.The bone-marrow niche in MDS and MGUS: implications for AML and MM.Deep sequencing and flow cytometric characterization of expanded effector memory CD8+CD57+ T cells frequently reveals T-cell receptor Vβ oligoclonality and CDR3 homology in acquired aplastic anemia.A Cytokine-Based Diagnostic Program in Pediatric Aplastic Anemia and Hypocellular Refractory Cytopenia of Childhood.Haploidentical BMT and post-transplant Cy for severe aplastic anemia: a multicenter retrospective study.Immune thrombocytopenia is associated with persistently deranged fibrosis-related seromarker profiles but low bone marrow fibrosis grades: A 2-year observational study on thrombopoietin receptor agonist treatment.Hypoalbuminemia is an independent prognostic factor for overall survival in myelodysplastic syndromes.Senescence of bone marrow mesenchymal stromal cells is accompanied by activation of p53/p21 pathway in myelodysplastic syndromes.The Critical Role of Inflammation in the Pathogenesis and Progression of Myeloid Malignancies.Activity of eltrombopag in severe aplastic anemia

P2860

Q26739239-4CDEEC5D-7243-4BCD-9F6C-42B0A6913657 Q26863182-A83E415D-46A9-4337-AD7F-DD4D59989DF5 Q27015288-53D80D00-C800-4BEE-B643-257F9B6B9586 Q28085299-72D08E40-4B54-4131-901B-08CEE2734230 Q33397165-20E01D58-FA37-4AAF-B58D-E869DE7BD223 Q33400949-90B9CF80-CD78-41AC-8AF1-FEFC8DEED53F Q33401328-F0D5612E-1D79-4DA9-9ADC-952896450D99 Q33405829-86B8D7B9-03E5-4E54-B449-CFEDE5C814F8 Q33412937-ECBA1E66-09C3-4522-89A5-88B9432F2678 Q34392449-5E8F9F0E-E625-4992-B1DC-D4D1B5099936 Q34407429-9BC5126F-98A0-4C33-BB21-8F00ABF459FC Q34555435-F67C2F7E-35FC-4DE2-8169-30FED9974BEA Q34667249-A97B33F6-95EA-4C35-8E15-7BE3AB58399E Q35119918-18AE9983-060A-4A7B-877C-C5895942B242 Q35214418-3A698AAF-781B-48E1-99EB-6F8B2DF721FE Q35230019-3A296C27-8329-4E0F-A8CA-8F6CB246DFDB Q36174878-042D91FF-3B28-409A-AB85-3B589D4C18C1 Q37134517-4E543BF2-68D8-40D1-B694-9B1680031777 Q37380379-D6881834-8FF7-41BD-89DE-A5B341A93A3C Q37555805-E2C4A8A3-441F-465A-B651-99BBF491A467 Q38061043-BD453D8A-3F18-460B-9B20-69FA2425F349 Q38083604-F8E134EA-27B8-4CA5-BFE8-D888106982B3 Q38101283-F85710B4-0661-42DD-B896-E33CCDD34A23 Q38473613-65831220-2F91-45EB-9E92-3C2843F1846E Q41200516-4FAD1D7E-F5D6-49FF-9A01-E4E2B81003F2 Q43182095-BDA8B9B8-4545-409D-BABA-7E42CCE38C48 Q49893762-554967E9-53C8-4F97-8801-9FA31B08E473 Q50114615-BC6C99EF-7B1B-451E-A449-BF0CEEB0E90B Q50118878-E26EA8ED-2809-447A-8CC9-85BD6ECA09E7 Q50282618-8F364966-143B-457E-BE41-144CBC6852DB Q51003191-D7DEEEAB-2070-48B6-A230-3AA1D56CBFD6 Q52732629-AF29A51F-149E-44B5-81ED-0415B1F98757 Q53121819-7DBDE3AB-2848-4970-9385-8A1D50A1B05F Q54348216-66EA210F-D7C4-4D2D-846F-9753FAD7F103 Q55024258-8648726F-B0AD-4272-8B17-84CCE58D3D53 Q59133385-2CF29A4C-060B-4FF0-8937-5F4881302E15

P2860

Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes.

http://www.wikidata.org/entity/Q34750590

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes.

@ast

Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes.

@en

Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes.

@nl

type

label

Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes.

@ast

Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes.

@en

Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes.

@nl

prefLabel

Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes.

@ast

Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes.

@en

Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes.

@nl

P1433

Q34750590-1B6ECC6D-807D-4884-81DC-F545B1573D11

P1476

Q34750590-88E13CDA-C72E-4577-93EA-E0A11280F3B5

P2093

Q34750590-24390756-F5C3-4DCB-AD2B-5BE835739AAD

Q34750590-265D606B-B258-4A99-B3B6-5A3E77710C37

Q34750590-413F8F90-2346-454D-A5E8-6771141EF762

Q34750590-4374C754-BA9E-465A-9ED2-AFD6A1BD5F05

Q34750590-47F9F8C1-8F55-460F-A408-A9024D38110D

Q34750590-54C70545-316E-4B06-9264-DC17AE537EB1

Q34750590-948D4BED-7474-437C-B5D3-F81299A9DDA5

Q34750590-BF1D51E8-97FE-4900-B267-7539F1083E2C

Q34750590-F125E510-BAF3-4F94-9BA5-75AE2215EA3A

P2860

Q34750590-0CC60D07-6A68-4BF7-AF5F-4884E8BDF38F

Q34750590-25778647-05F9-4FE2-B0F8-AB12397B6FB7

Q34750590-328B032D-D476-4707-94AB-7020E2208C46

Q34750590-60ED50F0-6F18-4928-A5C2-D3D20CC7BDE1

Q34750590-72A24621-3ABC-40E4-AEF7-8F502FCB8E81

Q34750590-790C7DC2-48A5-4D6F-BDC5-7EA1956B3ECA

Q34750590-79354648-5305-4253-95A9-6E1C53AE09C2

Q34750590-C1E72BDA-9967-4FD0-904D-354B5556D743

Q34750590-E1FA4C8C-8B24-4DB6-82A3-D7EB05DB0D4E

Q34750590-E4041B71-67DA-488E-8BAF-523FF044CC55

P304

Q34750590-F221A9F6-9870-4A79-9764-583E39F86940

P31

Q34750590-1FB1A113-0D31-4EAC-BD11-AD097AEE6D21

P356

Q34750590-5201CA29-0F0E-47B9-9092-3E5DF08332E5

P433

Q34750590-817B8D0F-D33F-414F-8F83-1C9C94F26596

P478

Q34750590-0D6177B5-1C0A-474D-8D59-D137D45F813B

P50

Q34750590-35E0CF58-6B91-4DF2-8F54-C871F40FB15E

P577

Q34750590-B24A68D4-7B52-4D9C-819C-DA1073D499D7

P5875

Q34750590-065A79F8-6F28-42E6-9200-9F2B77D476E1

P698

Q34750590-D913133D-F351-4FA5-A6C7-A44AD8575C64

P932

Q34750590-2B461A42-3EB6-4330-B605-9D2F177DB09A

P356

HAEMATOL.2010.030536

P1433

P1476

Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes

@en

P2093

Colin O Wu

http://www.w3.org/2001/XMLSchema#string

Courtney Prince

http://www.w3.org/2001/XMLSchema#string

J Philip McCoy

http://www.w3.org/2001/XMLSchema#string

Jaroslaw P Maciejewski

http://www.w3.org/2001/XMLSchema#string

Leigh Samsel

http://www.w3.org/2001/XMLSchema#string

Neal S Young

http://www.w3.org/2001/XMLSchema#string

Olga Nunez

http://www.w3.org/2001/XMLSchema#string

Rebecca D Ganetzky

http://www.w3.org/2001/XMLSchema#string

Xingmin Feng

http://www.w3.org/2001/XMLSchema#string

P2860

Transcriptional regulation of the human MIP-1alpha promoter by RUNX1 and MOZ

Current concepts in the pathophysiology and treatment of aplastic anemia

The World Health Organization (WHO) classification of the myeloid neoplasms

Serum thrombopoietin levels in patients with aplastic anaemia.

Concentrations of thrombopoietin in bone marrow in normal subjects and in patients with idiopathic thrombocytopenic purpura, aplastic anemia, and essential thrombocythemia correlate with its mRNA expression of bone marrow stromal cells.

Plasma thrombopoietin (TPO) levels and expression of TPO receptor on platelets in patients with myelodysplastic syndromes.

Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology?

Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine.

Report of an international working group to standardize response criteria for myelodysplastic syndromes.

Stem cell factor production by human marrow stromal fibroblasts.

P304

602-606

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2010.030536

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P50

Phillip Scheinberg

P577

2010-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49685150

http://www.w3.org/2001/XMLSchema#string

P698

21160069

http://www.w3.org/2001/XMLSchema#string

P932

3069238

http://www.w3.org/2001/XMLSchema#string